Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment

Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment

Oxaliplatin-fluoropyrimidine combination therapy is the gold standard treatment for patients with stage III colorectal cancer (CRC); however, treatment duration is now under re-evaluation. The aim of the study was the evaluation of the non-inferiority of three over six months treatment with FOLFOX o...

Full description

Bibliographic Details
Main Authors: Asimina Koulouridi, Ippokratis Messaritakis, Emmanouil Theodorakis, Maria Chondrozoumaki, Maria Sfakianaki, Nikolaos Gouvas, John Tsiaoussis, Dimitrios Mavroudis, Maria Tzardi, John Souglakos
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
colorectal cancer
stage III
adjuvant chemotherapy
circulating tumor cells
microbial DNA
three vs. six months adjuvant treatment
Online Access:https://www.mdpi.com/2072-6694/13/14/3552

Internet

https://www.mdpi.com/2072-6694/13/14/3552

Similar Items